HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruihua Ma Selected Research

6-methyladenine

12/2021HRD1-mediated METTL14 degradation regulates m6A mRNA modification to suppress ER proteotoxic liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruihua Ma Research Topics

Disease

8Neoplasms (Cancer)
02/2021 - 06/2013
2Infections
10/2020 - 06/2013
2Bites and Stings (Sting)
10/2020 - 02/2015
2Stroke (Strokes)
08/2009 - 01/2006
2Ischemic Stroke
05/2008 - 01/2006
1Liver Diseases (Liver Disease)
12/2021
1Lung Diseases (Lung Disease)
10/2020
1Tibial Fractures (Fracture, Tibial)
01/2019
1Neuroinflammatory Diseases
01/2019
1Cognitive Dysfunction
01/2019
1Inflammation (Inflammations)
01/2019
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
08/2018
1Ventilator-Induced Lung Injury
08/2018
1Acute Lung Injury
08/2018
1Hemangioendothelioma
08/2018
1Sepsis (Septicemia)
10/2016
1Melanoma (Melanoma, Malignant)
04/2015
1Burns
03/2014
1Carcinogenesis
06/2013
1Hypoxia (Hypoxemia)
06/2013
1Breast Neoplasms (Breast Cancer)
02/2013
1Cerebral Infarction
05/2008
1Transient Ischemic Attack
05/2008

Drug/Important Bio-Agent (IBA)

2Biocompatible Materials (Biomaterials)IBA
02/2021 - 12/2020
2DNA (Deoxyribonucleic Acid)IBA
10/2020 - 02/2015
1Messenger RNA (mRNA)IBA
12/2021
16-methyladenineIBA
12/2021
1cyclic guanosine monophosphate-adenosine monophosphateIBA
10/2020
1InterferonsIBA
10/2020
1Connexin 43 (Connexin43)IBA
01/2019
1Biological ProductsIBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2018
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2016
1LipopolysaccharidesIBA
10/2016
1lipoxin A4IBA
10/2016
1Interleukin-6 (Interleukin 6)IBA
10/2016
1Antiviral Agents (Antivirals)IBA
05/2016
1AntibodiesIBA
05/2016
1APTIBA
05/2016
1Ammonium CompoundsIBA
09/2015
1Glutamine (L-Glutamine)FDA Link
09/2015
1EnzymesIBA
04/2015
1FibrinIBA
04/2015
1PhosphoenolpyruvateIBA
04/2015
1Glucose (Dextrose)FDA LinkGeneric
04/2015
1GelsIBA
04/2015
1Therapeutic UsesIBA
02/2015
1VaccinesIBA
02/2015
1Cancer VaccinesIBA
02/2015
1Carbapenems (Carbapenem Antibiotics)IBA
03/2014
1AerosolsIBA
06/2013
1MicroRNAs (MicroRNA)IBA
06/2013
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
06/2013
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
02/2013
1pyreneIBA
02/2013
1CarcinogensIBA
02/2013
1Environmental CarcinogensIBA
02/2013
1Tissue Plasminogen Activator (Alteplase)FDA Link
08/2009
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2009
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2008
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2006
1Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2006

Therapy/Procedure

3Therapeutics
04/2016 - 05/2008
2Secondary Prevention
05/2008 - 01/2006
1Artificial Respiration (Mechanical Ventilation)
08/2018
1Splenectomy
10/2016
1Oncolytic Virotherapy
05/2016
1Drug Therapy (Chemotherapy)
05/2008
1Stents
05/2008
1Carotid Endarterectomy
05/2008